Detalles de la búsqueda
1.
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC.
JTO Clin Res Rep
; 5(1): 100622, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38292414
2.
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin.
Cancer Med
; 11(21): 3939-3948, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35343648
Resultados
1 -
2
de 2
1
Próxima >
>>